Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2023

Primary Completion Date

November 5, 2024

Study Completion Date

May 5, 2025

Conditions

Neuromyelitis OpticaEfgartigimod

Interventions

DRUG

Intravenous methylprednisolone (IVMP) and Efgartigimod

IVMP 800-1000mg/day for 3-5 days plus Efgartigimod (Efgartigimod: 10mg/kg IV on Day 1, Day 8, Day 15 and Day 22 after IVMP.)

DRUG

IVMP

IVMP 800-1000mg/day for 3-5 days.

All Listed Sponsors

lead

Feng Jinzhou

OTHER

NCT06118398 - Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders | Biotech Hunter | Biotech Hunter